Cargando…

Altered splicing of ATG16‐L1 mediates acquired resistance to tyrosine kinase inhibitors of EGFR by blocking autophagy in non‐small cell lung cancer

Despite the initial efficacy of using tyrosine kinase inhibitors of epidermal growth factor receptors (EGFR‐TKIs) for treating patients with non‐small cell lung cancer (NSCLC), resistance inevitably develops. Recent studies highlight a link between alternative splicing and cancer drug response. Ther...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hatat, Anne‐Sophie, Benoit‐Pilven, Clara, Pucciarelli, Amélie, de Fraipont, Florence, Lamothe, Lucie, Perron, Pascal, Rey, Amandine, Levra, Matteo Giaj, Toffart, Anne‐Claire, Auboeuf, Didier, Eymin, Beatrice, Gazzeri, Sylvie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9533692/ https://www.ncbi.nlm.nih.gov/pubmed/35593080 http://dx.doi.org/10.1002/1878-0261.13229

Ejemplares similares

Splice Variants of the RTK Family: Their Role in Tumour Progression and Response to Targeted Therapy
por: Abou-Fayçal, Cherine, et al.
Publicado: (2017)

Circular RNAs and RNA Splice Variants as Biomarkers for Prognosis and Therapeutic Response in the Liquid Biopsies of Lung Cancer Patients
por: de Fraipont, Florence, et al.
Publicado: (2019)

Translating Systems Medicine Into Clinical Practice: Examples From Pulmonary Medicine With Genetic Disorders, Infections, Inflammations, Cancer Genesis, and Treatment Implication of Molecular Alterations in Non-small-cell Lung Cancers and Personalized Medicine
por: Pinsolle, Julian, et al.
Publicado: (2019)

A VEGF-A/SOX2/SRSF2 network controls VEGFR1 pre-mRNA alternative splicing in lung carcinoma cells
por: Abou Faycal, Cherine, et al.
Publicado: (2019)

Advances and Therapeutic Perspectives in Extended-Stage Small-Cell Lung Cancer
por: Pierret, Thomas, et al.
Publicado: (2020)

Immunotherapy in NSCLC Patients With Brain and Leptomeningeal Metastases
por: Pierret, Thomas, et al.
Publicado: (2022)

Abnormal Expression of the Pre-mRNA Splicing Regulators SRSF1, SRSF2, SRPK1 and SRPK2 in Non Small Cell Lung Carcinoma
por: Gout, Stephanie, et al.
Publicado: (2012)

Partial response of pulmonary adenocarcinoma with symptomatic brain metastasis to nivolumab plus high-dose oral corticosteroid: a case report
por: Pluchart, Hélène, et al.
Publicado: (2017)

Implementing ctDNA Analysis in the Clinic: Challenges and Opportunities in Non-Small Cell Lung Cancer
por: Gobbini, Elisa, et al.
Publicado: (2020)

Complementarity of assembly-first and mapping-first approaches for alternative splicing annotation and differential analysis from RNAseq data
por: Benoit-Pilven, Clara, et al.
Publicado: (2018)

Epidemiology of oligometastatic non-small cell lung cancer: results from a systematic review and pooled analysis
por: Gobbini, Elisa, et al.
Publicado: (2021)

Factors associated with survival of patients with solid Cancer alive after intensive care unit discharge between 2005 and 2013
por: Gheerbrant, Hubert, et al.
Publicado: (2021)

ZRANB2 and SYF2-mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin
por: Tanaka, Iris, et al.
Publicado: (2020)

Splicing Programs and Cancer
por: Germann, Sophie, et al.
Publicado: (2012)

The sVEGFR1-i13 splice variant regulates a β1 integrin/VEGFR autocrine loop involved in the progression and the response to anti-angiogenic therapies of squamous cell lung carcinoma
por: Abou Faycal, Cherine, et al.
Publicado: (2018)

Alternative Splicing and Cancer
por: Auboeuf, Didier, et al.
Publicado: (2012)

ATG5 cancer mutations and alternative mRNA splicing reveal a conjugation switch that regulates ATG12–ATG5-ATG16L1 complex assembly and autophagy
por: Wible, Daric J., et al.
Publicado: (2019)

Repeated stereotactic radiosurgery for the treatment of relapsed brain metastases: is it time to give up whole-brain radiotherapy?
por: Nicosia, Luca, et al.
Publicado: (2020)

Pyrosequencing, a method approved to detect the two major EGFR mutations for anti EGFR therapy in NSCLC
por: Dufort, Sandrine, et al.
Publicado: (2011)

A new advance in alternative splicing databases: from catalogue to detailed analysis of regulation of expression and function of human alternative splicing variants
por: de la Grange, Pierre, et al.
Publicado: (2007)

New insights into minor splicing—a transcriptomic analysis of cells derived from TALS patients
por: Cologne, Audric, et al.
Publicado: (2019)

Splicing factor and exon profiling across human tissues
por: de la Grange, Pierre, et al.
Publicado: (2010)

Identification of protein features encoded by alternative exons using Exon Ontology
por: Tranchevent, Léon-Charles, et al.
Publicado: (2017)

The RNA helicase DDX17 controls the transcriptional activity of REST and the expression of proneural microRNAs in neuronal differentiation
por: Lambert, Marie-Pierre, et al.
Publicado: (2018)

Activity of sotorasib against brain metastases from NSCLC harboring KRAS p.G12C mutation: a case report
por: Inno, Alessandro, et al.
Publicado: (2023)

Different effects of Atg2 and Atg18 mutations on Atg8a and Atg9 trafficking during starvation in Drosophila()
por: Nagy, Péter, et al.
Publicado: (2014)

Mechanisms of resistance to EGFR tyrosine kinase inhibitors
por: Huang, Lihua, et al.
Publicado: (2015)

Imaging of EGFR and EGFR Tyrosine Kinase Overexpression in Tumors by Nuclear Medicine Modalities
por: Mishani, Eyal, et al.
Publicado: (2008)

Clinical activity of the EGFR tyrosine kinase inhibitor osimertinib in EGFR-mutant glioblastoma
por: Makhlin, Igor, et al.
Publicado: (2019)

Drug Tolerance to EGFR Tyrosine Kinase Inhibitors in Lung Cancers with EGFR Mutations
por: Suda, Kenichi, et al.
Publicado: (2021)

Nivolumab treatment in advanced non-small cell lung cancer: real-world long-term outcomes within overall and special populations (the UNIVOC study)
por: Assié, Jean-Baptiste, et al.
Publicado: (2020)

Noncanonical E2 recruitment by the autophagy E1 revealed by Atg7–Atg3 and Atg7–Atg10 structures
por: Kaiser, Stephen E., et al.
Publicado: (2012)

Closing the loop: Three musketeers of autophagy-ATG2, ATG18a, and ATG9
por: Mishra, Divya
Publicado: (2023)

Real-time imaging of cotranscriptional splicing reveals a kinetic model that reduces noise: implications for alternative splicing regulation
por: Schmidt, Ute, et al.
Publicado: (2011)

Influenza virus infection induces widespread alterations of host cell splicing
por: Ashraf, Usama, et al.
Publicado: (2020)

Mechanisms and Pathophysiological Roles of the ATG8 Conjugation Machinery
por: Lystad, Alf Håkon, et al.
Publicado: (2019)

Intra-fraction and Inter-fraction analysis of a dedicated immobilization device for intracranial radiation treatment
por: Ong, Chin Loon, et al.
Publicado: (2020)

Crystallization of the Atg12–Atg5 conjugate bound to Atg16 by the free-interface diffusion method
por: Noda, Nobuo N., et al.
Publicado: (2008)

Structural Insight and Development of EGFR Tyrosine Kinase Inhibitors
por: Amelia, Tasia, et al.
Publicado: (2022)

Alteration in tyrosine phosphorylation of cardiac proteome and EGFR pathway contribute to hypertrophic cardiomyopathy
por: Xu, Mingguo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9jl7rhb9m4766sbmufp2ujrfhk